Rejection is always painful, but it is particularly agonising to have a drug rejected at the point of regulatory approval. After spending months researching, preparing, manufacturing and quality checking a drug, only to be sent back to the drawing board, how can companies get back into their creationary swing straight away?

Scientists led a focus group study of 29 females experiencing recurrent UTIs in order to gain insight into the gaps in their care…

This breaking research suggests that alterations in diet and lifestyle choices may be able to decrease risks of prostate cancer development…

The United European Gastroenterology (UEG) Week Virtual 2021 illuminated a wide range of new insights and recommendations for…

The corporate environment is evolving, and ‘purpose’ is more important than ever to young recruits looking for their next role. We examine how the pharmaceutical industry is embracing the importance of purpose for retention, reputation, and brand differentiation

From drug development to disposal, how can all processes and functions be considered through a greener lens, and work towards a healthier and safer future?

The mRNA COVID-19 vaccine took only a year to develop – beating the previous fastest traditional vaccine development, held by the 1967 mumps vaccine, of four years. How does it differ from traditional vaccine technology?